v3.25.1
STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Operating expenses:    
Research and development $ 3,530,913 $ 1,728,078
General and administrative expenses 8,696,335 3,718,841
Total operating expenses 12,227,248 5,446,919
Loss from operations (12,227,248) (5,446,919)
Other (expense) income:    
Interest (expense) income, net (92,192) 150,904
Exchange loss, net (30,787)  
Total other (expense) income (122,979) 150,904
Loss before income taxes (12,350,227) (5,296,015)
Deferred income tax provision 503  
Net loss (12,349,724) (5,296,015)
Temporary Equity, Accrual of paid-in-kind dividends on Serise A Non-Voting Convertible Preferred Stock (514,105)  
Net loss attributable to common stockholders $ (12,863,829) $ (5,296,015)
Net loss per common share, basic (in dollars per share) $ (12.52) $ (7.05)
Net loss per common share, diluted (in dollars per share) $ (12.52) $ (7.05)
Weighted average number of shares outstanding - basic (in shares) 1,027,788 751,071
Weighted average number of shares outstanding - diluted (in shares) 1,027,788 751,071
Comprehensive loss    
Net loss $ (12,349,724) $ (5,296,015)
Foreign currency translation adjustment (3,862,987)  
Comprehensive loss $ (16,212,711) $ (5,296,015)

Source